Literature DB >> 30569735

Redox Regulation of Ion Channels and Receptors in Pulmonary Hypertension.

Laura Weise-Cross1, Thomas C Resta1, Nikki L Jernigan1.   

Abstract

Significance: Pulmonary hypertension (PH) is characterized by elevated vascular resistance due to vasoconstriction and remodeling of the normally low-pressure pulmonary vasculature. Redox stress contributes to the pathophysiology of this disease by altering the regulation and activity of membrane receptors, K+ channels, and intracellular Ca2+ homeostasis. Recent Advances: Antioxidant therapies have had limited success in treating PH, leading to a growing appreciation that reductive stress, in addition to oxidative stress, plays a role in metabolic and cell signaling dysfunction in pulmonary vascular cells. Reactive oxygen species generation from mitochondria and NADPH oxidases has substantial effects on K+ conductance and membrane potential, and both receptor-operated and store-operated Ca2+ entry. Critical Issues: Some specific redox changes resulting from oxidation, S-nitrosylation, and S-glutathionylation are known to modulate membrane receptor and ion channel activity in PH. However, many sites of regulation that have been elucidated in nonpulmonary cell types have not been tested in the pulmonary vasculature, and context-specific molecular mechanisms are lacking. Future Directions: Here, we review what is known about redox regulation of membrane receptors and ion channels in PH. Further investigation of the mechanisms involved is needed to better understand the etiology of PH and develop better targeted treatment strategies.

Entities:  

Keywords:  NADPH oxidase; calcium homeostasis; hypoxia; potassium channels; reactive oxygen species; reductive stress

Year:  2019        PMID: 30569735      PMCID: PMC7061297          DOI: 10.1089/ars.2018.7699

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Compartmentalization of Redox-Regulated Signaling in the Pulmonary Circulation.

Authors:  Stephen M Black; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-07-03       Impact factor: 8.401

Review 2.  Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.

Authors:  Dan Xu; Ya-Hui Hu; Xue Gou; Feng-Yang Li; Xi-Yu-Chen Yang; Yun-Man Li; Feng Chen
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

Review 3.  Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.

Authors:  Olena Rudyk; Philip I Aaronson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Redox and Inflammatory Signaling, the Unfolded Protein Response, and the Pathogenesis of Pulmonary Hypertension.

Authors:  Adiya Katseff; Raed Alhawaj; Michael S Wolin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 5.  The Biological Bases of Group 2 Pulmonary Hypertension.

Authors:  Ana I Fernández; Raquel Yotti; Ana González-Mansilla; Teresa Mombiela; Enrique Gutiérrez-Ibanes; Candelas Pérez Del Villar; Paula Navas-Tejedor; Christian Chazo; Pablo Martínez-Legazpi; Francisco Fernández-Avilés; Javier Bermejo
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

Review 6.  Glutathione in Protein Redox Modulation through S-Glutathionylation and S-Nitrosylation.

Authors:  Elena Kalinina; Maria Novichkova
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 7.  Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.

Authors:  Srikanth Karnati; Michael Seimetz; Florian Kleefeldt; Avinash Sonawane; Thati Madhusudhan; Akash Bachhuka; Djuro Kosanovic; Norbert Weissmann; Karsten Krüger; Süleyman Ergün
Journal:  Front Cardiovasc Med       Date:  2021-04-12

8.  Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension.

Authors:  Vinny Negi; Jimin Yang; Gil Speyer; Andres Pulgarin; Adam Handen; Jingsi Zhao; Yi Yin Tai; Ying Tang; Miranda K Culley; Qiujun Yu; Patricia Forsythe; Anastasia Gorelova; Annie M Watson; Yassmin Al Aaraj; Taijyu Satoh; Maryam Sharifi-Sanjani; Arun Rajaratnam; John Sembrat; Steeve Provencher; Xianglin Yin; Sara O Vargas; Mauricio Rojas; Sébastien Bonnet; Stephanie Torrino; Bridget K Wagner; Stuart L Schreiber; Mingji Dai; Thomas Bertero; Imad Al Ghouleh; Seungchan Kim; Stephen Y Chan
Journal:  Sci Adv       Date:  2021-10-20       Impact factor: 14.136

9.  Potassium channels as potential drug targets for limb wound repair and regeneration.

Authors:  Wengeng Zhang; Pragnya Das; Sarah Kelangi; Marianna Bei
Journal:  Precis Clin Med       Date:  2019-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.